Cargando…
Programmed death‐ligand 1 is a promising blood marker for predicting tumor progression and prognosis in patients with gastric cancer
Immune checkpoint inhibitor therapy has been clinically introduced for several malignancies, and its effectiveness has been confirmed by clinical trials. In particular, programmed cell death protein 1 (PD‐1) and programmed death‐ligand 1 (PD‐L1) are widely known as important immune checkpoint molecu...
Autores principales: | Amatatsu, Masahiko, Arigami, Takaaki, Uenosono, Yoshikazu, Yanagita, Shigehiro, Uchikado, Yasuto, Kijima, Yuko, Kurahara, Hiroshi, Kita, Yoshiaki, Mori, Shinichiro, Sasaki, Ken, Omoto, Itaru, Maemura, Kosei, Ishigami, Sumiya, Natsugoe, Shoji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834808/ https://www.ncbi.nlm.nih.gov/pubmed/29345842 http://dx.doi.org/10.1111/cas.13508 |
Ejemplares similares
-
The association of human endogenous retrovirus-H long terminal repeat-associating protein 2 (HHLA2) expression with gastric cancer prognosis
por: Shimonosono, Masataka, et al.
Publicado: (2018) -
Clinical utility of perioperative staging laparoscopy for advanced gastric cancer
por: Ishigami, Sumiya, et al.
Publicado: (2014) -
Clinical significance of primary tumor score determined by tumor depth and size in patients with resectable gastric cancer
por: Haraguchi, Naoto, et al.
Publicado: (2018) -
A long-term survivor of recurrent esophagogastric junction adenocarcinoma treated with multidisciplinary therapy: a case report
por: Tanaka, Takako, et al.
Publicado: (2020) -
A case report of curative distal gastrectomy for stage IV gastric cancer after chemoradiotherapy in a patient with a gastrojejunal gastric bypass
por: Shimonosono, Masataka, et al.
Publicado: (2016)